Schedule 13G ownership disclosure
Inspyr Therapeutics, Inc.
Security class unavailable · CUSIP: 45782A205
Event date: 2018-11-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,681,207
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-18-000105
- Form type
- SC 13G
- Filer
- Rebus Holdings, Inc.
- CIK
- CIK 1421204
- Filed
- Nov 26, 2018
- Reporting period
- Nov 21, 2018
- Description
- Schedule 13G beneficial ownership